AKT1 and non-small cell lung carcinoma: Brognard et al. [8] has demonstrated that Akt activity might promote therapeutic resistance in human non-small cell lung cancer cells and that LY294002 greatly potentiated chemotherapy-induced apoptosis in cells with high Akt levels, but not in cells with low Akt levels.